October 8, 2012 – A recent study conducted by a team of Japanese scientists has found that cetuximab, a drug commonly used in the treatment of colorectal cancer, is also an effective treatment for resistant mesothelioma. For many, the prognosis for a patient diagnosed with asbestos-related mesothelioma becomes a battle against time and current treatments do not always increase survival rates. For patients who do not benefit from conventional mesothelioma treatments, cetuximab offers new hope for prolonged survival.
A group of Belgium scientists are also currently studying the effects of adding cetuximab to traditional chemotherapy treatments in mesothelioma patients who experience a recurrence of their cancer after surgery. Since the research is currently in progress, final results of the study have not been made available. Scientists have reported that the initial phase of the cetuximab study has shown positive results when used in laboratory mice.
Philadelphia Mesothelioma Attorneys at the Shein Law Combine Knowledge and Experience for Successful Results
The Philadelphia mesothelioma attorneys at Shein Law have been working with victims of asbestos-related disease for over 25 years. Serving clients throughout the Pennsylvania, New Jersey and Delaware, the attorneys at Shein Law are committed to helping victims of asbestos exposure seek the justice and compensation they deserve. If you or a loved one has been diagnosed with an asbestos-related disease like mesothelioma or asbestosis, contact us to see how we can help you. Call us today at 1-877-SHEINLAW or contact us online.